Your browser doesn't support javascript.
loading
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans, Simone; Efficace, Fabio; Kyriakou, Charalampia; Freitas, Ana Carolina; Shamieh, Omar; Creutzberg, Carien L; Lehmann, Jens; Petranovic, Duska; Nagele, Eva; Bredart, Anne; Dong, Dong; Scholz, Christian W; Caocci, Giovanni; Molica, Stefano; Griskevicius, Laimonas; Xochelli, Aliki; Kieffer, Jacobien M; Agelink van Rentergem, Joost A; Alrjoub, Waleed; Mueller, Anja; Gomes Da Silva, Maria; Alves da Costa, Filipa; Malak, Sandra; Cocks, Kim; van de Poll-Franse, Lonneke V.
Afiliação
  • Oerlemans S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases Data Centre, Rome, Italy.
  • Kyriakou C; University College London Hospital, London, UK.
  • Freitas AC; Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal.
  • Shamieh O; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Creutzberg CL; Faculty of Medicine, The University of Jordan, Amman, Jordan.
  • Lehmann J; Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Petranovic D; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Nagele E; Clinical Hospital Center Rijeka, University of Rijeka, Rijeka, Croatia.
  • Bredart A; Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Dong D; Institut Curie, Psycho-Oncology Unit, Paris, France.
  • Scholz CW; Psychopathology and Health Process Laboratory (UR 4057), Paris University, Paris, France.
  • Caocci G; PSL University, Paris, France.
  • Molica S; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Griskevicius L; Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany.
  • Xochelli A; Hematology, Businco Hospital, University of Cagliari, Cagliari, Italy.
  • Kieffer JM; Azienda Ospedalier Ciaccio, Catanzaro, Italy.
  • Agelink van Rentergem JA; Department of Hematology, Hull University Teaching Hospitals, NHS Trust, Hull, UK.
  • Alrjoub W; Hematology, Oncology and Transfusion Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Mueller A; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Gomes Da Silva M; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Alves da Costa F; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Malak S; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Cocks K; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • van de Poll-Franse LV; Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany.
Cancer ; 129(17): 2727-2740, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37204189
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda